Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
8.99M
-
Shares change
-
+1.76M
-
Total reported value, excl. options
-
$45.2M
-
Value change
-
+$8.15M
-
Put/Call ratio
-
0.82
-
Number of buys
-
35
-
Number of sells
-
-29
-
Price
-
$5.03
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q1 2022
88 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q1 2022.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.99M shares
of 53.4M outstanding shares and own 16.82% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.25M shares), VANGUARD GROUP INC (1.52M shares), STATE STREET CORP (552K shares), GEODE CAPITAL MANAGEMENT, LLC (541K shares), Janney Montgomery Scott LLC (350K shares), MILLENNIUM MANAGEMENT LLC (320K shares), SABBY MANAGEMENT, LLC (259K shares), NORTHERN TRUST CORP (257K shares), HealthInvest Partners AB (255K shares), and Retirement Planning Co of New England, Inc. (244K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.